Quezada et al. and Xie et al. recently further claimed that tumor-reactive CD4+ T cells secrete a copious amount of IFN-γ to upregulate expression of MHC-class-II molecules on tumor cells and make them the target of cytotoxic CD4+ T cells after transfer into lymphopenic hosts [1], [2]. Here, IFNG is linked to neoplasm.